Ge, J., Wang, J., Wang, H., Jiang, X., Liao, Q., Gong, Q., . . . Zeng, Z. (2020). The BRAF V600E mutation is a predictor of the effect of radioiodine therapy in papillary thyroid cancer. J Cancer.
シカゴスタイル引用形Ge, Junshang, et al. "The BRAF V600E Mutation Is a Predictor of the Effect of Radioiodine Therapy in Papillary Thyroid Cancer." J Cancer 2020.
MLA引用形式Ge, Junshang, et al. "The BRAF V600E Mutation Is a Predictor of the Effect of Radioiodine Therapy in Papillary Thyroid Cancer." J Cancer 2020.
警告: この引用は必ずしも正確ではありません.